J M Wolff
- [GnRH antagonists--a new therapy option for advanced prostate cancer]J M Wolff
Urologische Klinik am St Cornelius Hospital, Allgemeines Krankenhaus, Viersen GmbH, Heesstrasse 10, Viersen
Aktuelle Urol 40:159-63. 2009..In contrast, gonadotrophin releasing hormone (GnRH) antagonists do not induce a testosterone surge and the level of testosterone decreases as rapidly as that known from a surgical castration...
- Drivers for change in the management of prostate cancer - guidelines and new treatment techniquesJ M Wolff
Department of Urology, Viersen General Hospital, Viersen, Germany
BJU Int 109:33-41. 2012..Novel techniques such as proton beam or carbon ion radiotherapy, which may offer improved and more localized dose distribution with reduced damage to normal tissue, are also examined...
- [Intermittent androgen deprivation in advanced prostate cancer: a review]J M Wolff
Urologische Klinik, AKH Viersen, Viersen
Aktuelle Urol 43:115-20. 2012..Although data about quality of life and overall survival are still limited, results seem to be comparable. In order to decide which patient groups are most likely to benefit from IAB, final phase III results need to be available...
- Intermittent androgen ablation as a treatment for prostate cancerJ M Wolff
Department of Urology, University of Rostock, Germany
Front Radiat Ther Oncol 36:66-71. 2002